Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993667 · ClinicalTrials.gov registry record · Phase 4
Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
A Phase 4 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT01993667: Completed Phase 4 study, sponsored by University of Utah.
NCT01993667 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 130 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01993667, a Phase 4 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
Primary Outcome
Lake Louise Score, A total score of 3 to 5 indicates mild AMS. A score of 6 or more signifies severe AMS. Minimum value - 0, Maximum = 15
Interventions
- DRUG Low Dose Acetazolamide
- DRUG Normal Dose Acetazolamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
What the finished NCT01993667 record still lists
NCT01993667 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Dose Acetazolamide is the first listed.
NCT01993667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01993667 about?
NCT01993667 is a clinical study titled "Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing". This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
What is the current status of trial NCT01993667?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2012-03. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01993667?
The interventions under investigation include: Low Dose Acetazolamide (DRUG), Normal Dose Acetazolamide (DRUG).
Who is sponsoring clinical trial NCT01993667?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01993667's enrollment target sits among peer trials
130 622nd of 2000 higher than 1,370 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia